Branislava Milenković
A5062564439- Chronic Obstructive Pulmonary Disease (COPD) Research
- Asthma and respiratory diseases
- Respiratory and Cough-Related Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory Support and Mechanisms
- Delphi Technique in Research
- Allergic Rhinitis and Sensitization
- Tracheal and airway disorders
- Gastroesophageal reflux and treatments
- Neonatal Respiratory Health Research
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Pediatric health and respiratory diseases
- COVID-19 Clinical Research Studies
- Inhalation and Respiratory Drug Delivery
- Cystic Fibrosis Research Advances
- Health and Medical Studies
- Pulmonary Hypertension Research and Treatments
- Sarcoidosis and Beryllium Toxicity Research
- Lung Cancer Treatments and Mutations
- Pleural and Pulmonary Diseases
- Tumors and Oncological Cases
- Dysphagia Assessment and Management
- Salivary Gland Tumors Diagnosis and Treatment
- Tuberculosis Research and Epidemiology
Institute for Pulmonary Diseases of Vojvodina
2013-2025
Univerzitetski Klinički Centar Srbije
2011-2025
University of Babylon
2025
University of Belgrade
2015-2024
Centar za Promociju Nauke
2007-2021
Institut za Reumatologiju
2021
University Hospital Dubrava
2018
University Hospital Centre Zagreb
2018
University of Zagreb
2018
University of Douala
2018
Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no approved therapies and few large-scale, representative epidemiological studies. The EMBARC (European Multicentre Audit Research Collaboration) registry a prospective, pan-European observational study patients with bronchiectasis. inclusion criterion primary clinical diagnosis bronchiectasis consisting of: 1) history consistent bronchiectasis; 2) computed tomography demonstrating Core exclusion criteria...
Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients this region. Participation the Phenotypes COPD Europe (POPE) study was offered to stable with real-life setting. The primary aim assess prevalence according predefined criteria. Secondary aims included analysis differences symptom load, comorbidities pharmacological treatment. 3362 were...
To the Editor, A novel strain of human coronaviruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), named by International Committee on Taxonomy Viruses (ICTV),1 has recently emerged and caused an infectious disease. This disease is referred to as "coronavirus 2019" (COVID-19) World Health Organization (WHO).2 The US Centers for Disease Control Prevention (CDC) have proposed that "People with moderate asthma may be at higher risk getting very sick from COVID-19. COVID-19 can...
Asthma is commonly reported in patients with a diagnosis of bronchiectasis.
Background A validated 4-point sputum colour chart can be used to objectively evaluate the levels of airway inflammation in bronchiectasis patients. In European Bronchiectasis Registry (EMBARC), we tested whether would associated with disease severity and clinical outcomes. Methods We a prospective, observational registry adults conducted 31 countries. Patients who did not produce spontaneous were excluded from analysis. The Murray was at baseline follow-up visits. Key outcomes frequency...
Abstract Background Inflammation, oxidative stress and an imbalance between proteases protease inhibitors are recognized pathophysiological features of chronic obstructive pulmonary disease (COPD). The aim this study was to evaluate serum levels matrix metalloproteinase-9 (MMP-9) tissue inhibitor metalloproteinase-1 (TIMP-1) in patients with COPD assess their relationship lung function, symptom severity scores recent acute exacerbations. Methods In observational cohort study, MMP-9 TIMP-1...
Several composite markers have been proposed for risk assessment in chronic obstructive pulmonary disease (COPD). However, choice of parameters and score complexity restrict clinical applicability. Our aim was to provide validate a simplified COPD index independent lung function.The PROMISE study (n=530) used develop novel prognostic index. Index performance assessed regarding 2-year COPD-related mortality all-cause mortality. External validity tested stable exacerbated patients the ProCOLD,...
Hyaluronic acid (HA) and its degradation products play an important role in lung pathophysiology airway remodelling chronic obstructive pulmonary disease (COPD).We investigated if HA degrading enzyme hyaluronidase (HYAL)-1 are associated with COPD severity outcome.Serum was assessed a discovery cohort of 80 patients at stable state exacerbations. HA, HYAL-1 enzymatic activity were evaluated state, exacerbations 4 weeks after 638 from the PROMISE validation cohort.In cohort, serum higher...
We evaluated coagulation abnormalities via traditional tests and rotational thromboelastometry (ROTEM) in a group of 94 patients with confirmed SARS-CoV-2 infection different severity pneumonia (34 moderate, 25 severe, 35 critical) the hypothesis that ROTEM parameters differed by coronavirus disease 2019 (COVID-19) severity. Shorter than normal clotting time (CT) higher maximum clot firmness (MCF) extrinsic (EXTEM) fibrinogen (FIBTEM), shorter EXTEM formation (CFT), α-angle were classified...
Abstract Background Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple comorbidities, which may influence survival but go under-recognised in clinical practice. We therefore report comorbidity, antifibrotic treatment use and of patients IPF observed the multi-national EMPIRE registry. Methods For this prospective cohort, demographics, causes death were analysed. Comorbidities noted by treating physician based on patient’s past medical history or as reported during...
Introduction Current bronchiectasis guidelines advise against the use of inhaled corticosteroids (ICS) except in patients with associated asthma, allergic bronchopulmonary aspergillosis (ABPA) and/or chronic obstructive pulmonary disease (COPD). This study aimed to describe ICS across Europe. Methods Patients were enrolled into European Bronchiectasis Registry from 2015 2022. grouped users and non-users at baseline clinical characteristics investigated. followed up for outcomes exacerbation,...
<title>Abstract</title> 15q26 deletion syndrome is a rare genetic condition caused by the of terminal end long arm chromosome 15 (Drayer's syndrome). Clinical presentation usually implies intrauterine growth restriction, postnatal failure, varying degrees intellectual disability, developmental delay, typical facial appearance, brachydactyly and diaphragmatic hernia. Lymphangioleiomiomatosis (LAM) disease affecting multiple organs, which almost exclusively afflicts women. Typical LAM...
The BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity) index is well-validated for mortality prediction in chronic obstructive pulmonary disease (COPD). Concentrations of plasma pro-adrenomedullin, a surrogate mature adrenomedullin, independently predicted 2-year among inpatients with COPD exacerbation. We compared accuracy initial pro-adrenomedullin level, and components, alone or combined, predicting 1-year all-cause multicentre, multinational observational cohort...
Abstract Background and objective Gastroesophageal reflux disease (GERD) symptoms are associated with a higher risk of chronic obstructive pulmonary (COPD) exacerbation. We hypothesize that treatment proton pump inhibitors reduces the exacerbation in patients stable COPD. Methods A total 638 COPD for ≥6 weeks, ≥10 pack‐years smoking Global Initiative Chronic Obstructive Lung Disease II–IV seeking care tertiary hospitals eight European countries Predicting Outcome using Systemic Markers...
Older adults, especially men and/or those with diabetes, hypertension, obesity, are prone to severe COVID-19. In some countries, older particularly residing in nursing homes, have been prioritized receive COVID-19 vaccines due high risk of death. very rare instances, the can induce anaphylaxis, and management anaphylaxis people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis its Impact on Asthma, European Academy Allergy Clinical Immunology, Geriatric Medicine Society)...